Australia Markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
126.72+1.67 (+1.34%)
At close: 4:02PM EDT
126.10 -0.62 (-0.49%)
After hours: 06:42PM EDT
Currency in USD

Valuation measures

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3129.70
52-week low 3103.13
50-day moving average 3122.25
200-day moving average 3119.62

Share statistics

Avg vol (3-month) 34.67M
Avg vol (10-day) 35.65M
Shares outstanding 51.78B
Implied shares outstanding 6N/A
Float 81.76B
% held by insiders 10.72%
% held by institutions 175.71%
Shares short (14 June 2021) 414.01M
Short ratio (14 June 2021) 41.77
Short % of float (14 June 2021) 40.81%
Short % of shares outstanding (14 June 2021) 40.79%
Shares short (prior month 13 May 2021) 414.2M

Dividends & splits

Forward annual dividend rate 41.8
Forward annual dividend yield 41.51%
Trailing annual dividend rate 31.62
Trailing annual dividend yield 31.30%
5-year average dividend yield 41.74
Payout ratio 447.96%
Dividend date 314 Nov 2021
Ex-dividend date 413 July 2021
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 15.33%
Operating margin (ttm)18.54%

Management effectiveness

Return on assets (ttm)6.20%
Return on equity (ttm)17.81%

Income statement

Revenue (ttm)37.34B
Revenue per share (ttm)21.04
Quarterly revenue growth (yoy)35.30%
Gross profit (ttm)19.61B
EBITDA 10.36B
Net income avi to common (ttm)5.69B
Diluted EPS (ttm)3.19
Quarterly earnings growth (yoy)217.90%

Balance sheet

Total cash (mrq)8.37B
Total cash per share (mrq)4.71
Total debt (mrq)18.44B
Total debt/equity (mrq)54.59
Current ratio (mrq)1.75
Book value per share (mrq)18.89

Cash flow statement

Operating cash flow (ttm)9.82B
Levered free cash flow (ttm)6.36B